Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'26 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Cyient Reduces FY25 Outlook Analysts Share Stock Price Target

    Alarming Quarter: Cyient Reduces FY25 Outlook; Analysts Share Stock Price Target


    Finance Outlook India Team | Friday, 26 July 2024

    Cyient Ltd, whose shares have been down 17.50 percent in the previous year, presented a dismal set of June quarter results on all fronts. The IT business reported sales and margins that were far below than analysts' expectations. Cyient's management also decreased its FY25 DET (digital, engineering, and technology) revenue growth target to flat YoY from high single digits, which analysts noted was the lowest among its midcap and small-cap rivals.  

    "Cyient now requires 3 percent or more CQGR to meet its FY25 flat YoY revenue target, which we believe is a hard order given broad-based deterioration. Cheap values restrict the possible downside. We are lowering consolidated FY25/26 EPS by 15%/12% due to a substantial reduction in DLM expectations," Nuvama Institutional Equities stated.

    Nuvama described Cyient's first-quarter results as surprising and stated that only realistic values can salvage the company. The local brokerage has reduced its earnings forecasts for September 2026 to 20 times from 22 times due to lesser growth visibility, yielding a target price of Rs 1,840 from Rs 2,120 before.

    "Cyient (DET) announced a miss against lowered expectations. The top-line performance was unimpressive (5% quarterly decrease), with revenue declining across verticals and flowing through the P&L, resulting in a 250 basis point quarterly EBIT margin decline. The business predicts flat revenues in FY2025E (previously high single-digit growth), which we believe is still ambitious. We reduced our profit forecast by 14-18% for FY2025-27E. Kotak Institutional Equities stated that the model's fundamental strength remains, notwithstanding a few challenges in its updated estimates.

    This firm maintained its 'Buy' rating on the company but reduced its fair value objective to Rs 2,050 from Rs 2,275 before. Cyient management anticipates growth to resume from Q2FY25, with H2 outperforming H1.

    Nuvama said that the EBIT margin for the DET business was 13.5%, a steep drop of 250 basis points sequentially owing to revenue reduction headwinds. Due to the uncertain growth scenario, the margin forecast for FY25 has been revoked. Cyient aims to attain a 1 percent departure rate margin by Q4FY25, compared to 16 percent for the entire year FY25 previously.

    "Cyient dramatically dropped guidance and will be one of the lowest among midcap/small-cap peers - which looks to be a difficult order right now. The broad-based decrease across verticals casts doubt on the growth recovery route. "We remain negative on Cyient, even though cheap valuations limit the downside potential," Nuvama added.

    The brokerage values Cyient's DET business at 20 times FY26E PE and DLM at current market capitalization, after adding a 20% Holdco discount.



    Read More:

    ConvoZen Launches End-to-End Conversational AI

    India & France Revise Tax Treaty, Scrap MFN Clause, Ease Dividends

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25